Insider transactions

J Stark Phd Thompson

CIK 1241146 · last filed 2021-08-11

J Stark Phd Thompson is a corporate insider who has filed 9 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for MXCT, was dated Aug 11, 2021. Across all open-market trades the lifetime net is −$77.9K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
9
Lifetime Open-Market Net
-$77.9K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

LMNX price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MXCT Director — $1.51 — $0 1 2021-08-11
ORE PHARMACEUTICAL HOLDINGS INC. (ORXE) Delisted Director — — — $0 1 2009-10-22
LUMINEX CORP (LMNX) Delisted Director 18,289 $9.16 $167.5K -$88.6K 3 2008-12-01
ORE PHARMACEUTICAL HOLDINGS INC. (ORXED) Delisted Director — — — $0 1 2008-05-27
ORE PHARMACEUTICAL HOLDINGS INC. (GLGC) Delisted Director 12,500 — — $10.7K 3 2007-11-27

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-08-11 MXCT Grant (A) — $0 EDGAR
2009-10-22 ORE PHARMACEUTICAL HOLDINGS INC. (ORXE) Delisted Grant (A) — $0 EDGAR
2008-12-01 LUMINEX CORP (LMNX) Delisted Sell (S) −4,000 -$88.6K EDGAR
2008-05-27 LUMINEX CORP (LMNX) Delisted Grant (A) +3,251 $0 EDGAR
2008-05-27 ORE PHARMACEUTICAL HOLDINGS INC. (ORXED) Delisted Grant (A) — $0 EDGAR
2007-11-27 ORE PHARMACEUTICAL HOLDINGS INC. (GLGC) Delisted Buy (P) +7,000 $5.8K EDGAR
2007-06-07 ORE PHARMACEUTICAL HOLDINGS INC. (GLGC) Delisted Grant (A) — $0 EDGAR
2007-05-29 LUMINEX CORP (LMNX) Delisted Grant (A) +8,038 $0 EDGAR
2007-02-27 ORE PHARMACEUTICAL HOLDINGS INC. (GLGC) Delisted Buy (P) +2,800 $4.9K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.